Endothelin Contributes to Basal Vascular Tone and Endothelial Dysfunction in Human Obesity and Type 2 Diabetes
Endothelin Contributes to Basal Vascular Tone and Endothelial Dysfunction in Human Obesity and Type 2 Diabetes Kieren J. Mather 1 , Bahram Mirzamohammadi 1 , Amale Lteif 1 , Helmut O. Steinberg 1 and Alain D. Baron 1 2 1 Division of Endocrinology & Metabolism, Indiana University-Purdue Universit...
Gespeichert in:
Veröffentlicht in: | Diabetes (New York, N.Y.) N.Y.), 2002-12, Vol.51 (12), p.3517-3523 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Endothelin Contributes to Basal Vascular Tone and Endothelial Dysfunction in Human Obesity and Type 2 Diabetes
Kieren J. Mather 1 ,
Bahram Mirzamohammadi 1 ,
Amale Lteif 1 ,
Helmut O. Steinberg 1 and
Alain D. Baron 1 2
1 Division of Endocrinology & Metabolism, Indiana University-Purdue University Indianapolis School of Medicine, Indianapolis,
Indiana
2 Amylin Pharmaceuticals, Indianapolis, Indiana
Abstract
Endothelium-dependent vasodilation is impaired in clinical states of insulin resistance such as obesity and type 2 diabetes.
Individuals who have hyperinsulinemic insulin resistance have relatively elevated circulating levels of endothelin (ET)-1,
suggesting that ET-1 may be important in the endothelial dysfunction and alterations of vascular tone in these conditions.
In 8 lean subjects, 12 nondiabetic obese subjects, and 8 subjects with type 2 diabetes, we measured basal and methacholine-stimulated
rates of leg blood flow (LBF) and total serum nitrates (NOx) before and after the intrafemoral arterial administration of
BQ123, a specific blocker of ET A receptors. BQ123 produced significant vasodilation in the obese and type 2 diabetic subjects (leg vascular resistance = mean
arterial pressure/LBF fell by 34 and 36%; P < 0.005) but not in the lean subjects (13%; P = NS, P = 0.018 comparing all groups). ET A blockade did not change basal NOx flux (NOx*LBF). This suggests increased basal ET-1 constrictor tone among obese and type
2 diabetic subjects. BQ123 corrected the baseline defect in endothelium-dependent vasodilation seen in obese and type 2 diabetic
subjects, suggesting an important contribution of ET-1 to endothelial dysfunction in these subjects. In contrast to basal
conditions, stimulated NOx flux was augmented by BQ123 in obese and type 2 diabetic subjects but not in L subjects ( P = 0.04), suggesting a combined effect of ET A blockade to reduce constrictor tone and augment dilator tone. Endothelin seems to contribute to endothelial dysfunction and
the regulation of vascular tone in human obesity and type 2 diabetes.
Footnotes
Address correspondence and reprint requests to Kieren Mather, MD, Division of Endocrinology & Metabolism, Department of Medicine,
Indiana University School of Medicine, CL459, 541 North Clinical Dr., Indianapolis, IN 46202. E-mail: kmather{at}iupui.edu .
Received for publication 27 November 2001 and accepted in revised form 26 August 2002.
ET, endothelin; HOMA-IR, homeostasis model assessment-insulin resistance; LBF, leg bl |
---|---|
ISSN: | 0012-1797 1939-327X |
DOI: | 10.2337/diabetes.51.12.3517 |